Modivcare Has Revised Its 2024 Adjusted EBITDA Forecast From $185M–$195M To $170M–$180M Due To Pricing Accommodations In NEMT Segment. The Company Also Anticipates 2025 Adjusted EBITDA Growth Of Over 10%
Portfolio Pulse from Benzinga Newsdesk
Modivcare has revised its 2024 adjusted EBITDA forecast downwards due to pricing accommodations in its NEMT segment, but expects over 10% growth in 2025.
September 16, 2024 | 10:07 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Modivcare has lowered its 2024 adjusted EBITDA forecast from $185M–$195M to $170M–$180M due to pricing accommodations in its NEMT segment. However, the company expects over 10% growth in adjusted EBITDA for 2025.
The downward revision of the 2024 EBITDA forecast suggests potential short-term financial challenges, likely impacting the stock negatively. However, the positive outlook for 2025 may mitigate long-term concerns.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100